Journal of hypertension
-
Journal of hypertension · Nov 2003
Randomized Controlled Trial Clinical TrialOrlistat in hypertensive overweight/obese patients: results of a randomized clinical trial.
To assess the effect of orlistat plus diet compared with diet alone in promoting weight loss and blood pressure reduction in hypertensive, overweight/obese patients. ⋯ In both groups there was a reduction in weight, blood pressure and metabolic parameters. The orlistat group performed better in reducing weight, DBP, glucose and cholesterol. Results show that even a small reduction in weight helps to control blood pressure and glucose. The cost-benefit of the use of orlistat should be evaluated for hypertensive obese patients.